Fluconazole and Helicobacter pylori identification test positive - a phase IV clinical study of FDA data

Summary:

Helicobacter pylori identification test positive is reported only by a few people who take Fluconazole.

The phase IV clinical study analyzes which people take Fluconazole and have Helicobacter pylori identification test positive. It is created by eHealthMe based on reports of 53,330 people who have side effects while taking Fluconazole from the FDA, and is updated regularly.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On May, 22, 2022

53,330 people reported to have side effects when taking Fluconazole.
Among them, 2 people (0.0%) have Helicobacter pylori identification test positive.


What is Fluconazole?

Fluconazole has active ingredients of fluconazole. It is often used in vaginal yeast infection. eHealthMe is studying from 54,434 Fluconazole users for its effectiveness, alternative drugs and more.

What is Helicobacter pylori identification test positive?

Helicobacter pylori identification test positive is found to be associated with 228 drugs and 120 conditions by eHealthMe.

Number of Fluconazole and Helicobacter pylori identification test positive reports submitted per year:

Could Fluconazole cause Helicobacter pylori identification test positive?

Time on Fluconazole when people have Helicobacter pylori identification test positive *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Helicobacter pylori identification test positive when taking Fluconazole *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Helicobacter pylori identification test positive when taking Fluconazole *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common drugs people take besides Fluconazole *:

  1. Ramipril: 1 person, 50.00%
  2. Celecoxib: 1 person, 50.00%
  3. Celebrex: 1 person, 50.00%
  4. Bextra: 1 person, 50.00%
  5. Bactrim: 1 person, 50.00%
  6. Atorvastatin Calcium: 1 person, 50.00%
  7. Atenolol: 1 person, 50.00%
  8. Aspirin: 1 person, 50.00%
  9. Acetaminophen: 1 person, 50.00%

Common side effects people have besides Helicobacter pylori identification test positive *:

  1. White Blood Cell Count Decreased: 1 person, 50.00%
  2. Faecal Occult Blood Positive: 1 person, 50.00%
  3. Azotaemia (excess of urea or other nitrogenous compounds in the blood): 1 person, 50.00%
  4. Blood Pressure Diastolic Decreased: 1 person, 50.00%
  5. Blood Urea Increased: 1 person, 50.00%
  6. Chest Pain: 1 person, 50.00%
  7. Dizziness: 1 person, 50.00%
  8. Drug Toxicity: 1 person, 50.00%
  9. Enlarged Prostate: 1 person, 50.00%
  10. Epigastric Discomfort: 1 person, 50.00%

Common conditions people have *:

  1. Joint Pain: 1 person, 50.00%
  2. Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Fluconazole and have Helicobacter pylori identification test positive?

Check whether Helicobacter pylori identification test positive is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of Fluconazole:

Helicobacter pylori identification test positive treatments and more:

COVID vaccines that are related to Helicobacter pylori identification test positive:

How severe was Helicobacter pylori identification test positive and when was it recovered:

Expand to all the drugs that have ingredients of fluconazole:

All the drugs that are associated with Helicobacter pylori identification test positive:

All the conditions that are associated with Helicobacter pylori identification test positive:

How the study uses the data?

The study uses data from the FDA. It is based on fluconazole (the active ingredients of Fluconazole) and Fluconazole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: